Kineta
Biotechnology Research
Seattle, WA 3,752 followers
Developing next-generation immunotherapies for cancer patients!
About us
Kineta is a clinical stage biotechnology company with a mission to develop next-generation immunotherapies that transform patients’ lives.
- Website
-
http://www.kinetabio.com
External link for Kineta
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Seattle, WA
- Type
- Public Company
- Founded
- 2008
- Specialties
- Antivirals, Chronic Pain, Immuno-oncology, Biodefense, Immunology, Virology, Lassa fever, and Neuroscience
Locations
-
Primary
Seattle, WA, US
Employees at Kineta
Updates
-
Announcing that Kineta has reopened enrollment for our VISTA-101 Clinical Trial Evaluating KVA12123 and a combination arm utilizing KVA12123 together with Merck’s anti-PD-1 therapy, KEYTRUDA® (pembrolizumab) https://lnkd.in/g5gAzvMF #cancer #immunotherapy #clinicaltrials